Stockreport

FDA official calls UniQure's gene therapy a ‘failed' treatment for Huntington's disease [CNBC]

uniQure N.V. - Ordinary Shares  (QURE) 
Last uniqure n.v. - ordinary shares earnings: 4/29 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: uniqure.com/investors-newsroom/overview.php
PDF The official said UniQure is the “latest company to make a failed therapy for Huntington's patients.” UniQure and the FDA are engaged in a highly public dispute over [Read more]